Intervention

oxaliplatin

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting0
Common conditions25
Lead sponsors shown14
Advertisement

Clinical trials

15 shown
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701 · 2022-07-05
ACTIVE_NOT_RECRUITING
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)NCT04210115 · 2020-02-28
COMPLETED
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)NCT03675737 · 2018-11-08
COMPLETED
Oxaliplatin in Treating Patients With Metastatic Breast CancerNCT02077998 · 2015-05-01
COMPLETED
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsNCT01233505 · 2010-10-01
TERMINATED
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryNCT00513266 · 2007-06-01
UNKNOWN
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)NCT00406302 · 2007-01-01
COMPLETED
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate CancerNCT01338792 · 2006-06-01
COMPLETED
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLCNCT00356941 · 2006-04-01
TERMINATED
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerNCT00343408 · 2005-11-29
COMPLETED
Gemcitabine and Oxaliplatin in Treating Patients With Metastatic CancerNCT00274859 · 2005-08-01
UNKNOWN
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00305786 · 2005-08-01
COMPLETED
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsNCT00227617 · 2005-06-08
TERMINATED
Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous ChemotherapyNCT00006121 · 2000-05-01
TERMINATED
Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerNCT00004126 · 1999-11-01
COMPLETED

Common conditions

Lung Cancer5Colorectal Cancer2Stage IV Breast Cancer2Unspecified Adult Solid Tumor, Protocol Specific2Adenocarcinoma of the Pancreas1Adenocarcinoma of the Stomach1Advanced Colorectal Cancer (Part 1)1BRCA1 Mutation Carrier1BRCA2 Mutation Carrier1Breast Cancer1Carcinoma, Non-small-cell Lung1Esophageal Adenocarcinoma (EAC)1Esophageal Squamous Cell Carcinoma (ESCC)1Gastroesophageal Junction Carcinoma (GEJC)1Gastrointestinal Carcinoid Tumor1Glioma1Hormone-resistant Prostate Cancer1Islet Cell Tumor1Melanoma1Metastatic Cancer1Neoplastic Syndrome1Neuroendocrine Tumor1Non-Small-Cell Lung Cancer1Ovarian Mucinous Cystadenocarcinoma1Recurrent Breast Cancer1

Leading sponsors

Merck Sharp & Dohme LLC 2 Centre Hospitalier Universitaire Vaudois 1 European Organisation for Research and Treatment of Cancer - EORTC 1 GERCOR - Multidisciplinary Oncology Cooperative Group 1 Masonic Cancer Center, University of Minnesota 1 National Cancer Institute (NCI) 1 NCIC Clinical Trials Group 1 Pfizer 1 University of California, Davis 1 University of California, San Francisco 1 University of Chicago 1 University of Miami 1 University of Southern California 1 Wolfgang Hilbe 1

Trial status mix

COMPLETED8
TERMINATED4
UNKNOWN2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE28
PHASE14
PHASE33
EARLY_PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.